Amy Bannister
Family Medicine · Gilroy, CANPI 1700475472
Payments from drug & device makers
Across 394 payments — averaging $20.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Boehringer Ingelheim$1K
- Novo Nordisk$793
- Amgen$762
- Pfizer$532
- GSK$476
- plus $3K from 29 others
What the payments were for
- Food & beverage$8,123100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 53 | $1,560 |
| Boehringer Ingelheim | 56 | $1,187 |
| Novo Nordisk | 49 | $793 |
| Amgen | 40 | $762 |
| Pfizer | 27 | $532 |
| GSK | 25 | $476 |
| Merck | 21 | $472 |
| AbbVie | 18 | $380 |
| Lilly USA, LLC | 24 | $366 |
| Abbott | 15 | $249 |
| Bayer | 8 | $162 |
| Exact Sciences | 6 | $133 |
| Philips North America LLC | 6 | $120 |
| Mylan Specialty L.p. | 3 | $95 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $89 |
| Viiv Healthcare Company | 4 | $84 |
| Amarin Pharma, Inc. | 5 | $84 |
| Avanir Pharmaceuticals, Inc. | 3 | $74 |
| Xeris Pharmaceuticals, Inc. | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Sanofi-aventis U.S. LLC | 3 | $62 |
| Currax Pharmaceuticals LLC | 2 | $32 |
| Johnson & Johnson | 2 | $29 |
| Si-bone, Inc. | 1 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Paratek Pharmaceuticals, Inc. | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Novartis | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Verity Pharmaceuticals Inc. | 1 | $15 |
| Globus Medical | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,143 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 80 | $89,765 |
| OzempicSemaglutide | 93 | $87,821 |
| MounjaroTirzepatide | 58 | $59,619 |
| FarxigaDapagliflozin Propanediol | 45 | $55,522 |
| VascepaIcosapent Ethyl | 50 | $41,072 |
| JanuviaSitagliptin Phosphate | 26 | $32,737 |
| EliquisApixaban | 15 | $26,220 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $20,142 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 16 | $18,850 |
| RybelsusSemaglutide | 15 | $18,340 |
| TrulicityDulaglutide | 14 | $15,340 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $13,620 |
| Repatha SureclickEvolocumab | 20 | $12,996 |
| LinzessLinaclotide | 14 | $11,541 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 12 | $5,338 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr | $1,187 | $108,61596 claims |
| Novo NordiskOzempic, Rybelsus | $793 | $106,161108 claims |
| Lilly USA, LLCMounjaro, Trulicity | $366 | $74,95972 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,560 | $69,14364 claims |
| MerckJanuvia | $472 | $32,73726 claims |
| PfizerEliquis | $532 | $26,22015 claims |
| GSKTrelegy Ellipta | $476 | $20,14229 claims |
| AbbVieLinzess | $380 | $11,54114 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $62 | $5,33812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.
Other family medicine in Gilroy
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.